Bruker Corp
(FRA:BKD)
€
54.16
0.16 (0.3%)
Market Cap: 8.54 Bil
Enterprise Value: 10.52 Bil
PE Ratio: 25.45
PB Ratio: 5.19
GF Score: 89/100 Bruker Corp at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 11, 2021 / 03:00PM GMT
Release Date Price:
€56
(-1.75%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
Great. Good morning, everybody. Thank you for joining the 2021 Bank of America Health Care Conference. I'm Derik De Bruin, the Senior Life Sciences and Diagnostic Tools analyst. My colleague, Mike Ryskin, is also here. Our next company up for presenting is Bruker Corp. With us today from Bruker is Chief Executive Officer, Frank Laukien; President, Bruker Nano Group, Mark Munch; and Head of Investor Relations, Miroslava Minkova. Frank, Mark, Miroslava, welcome. Thank you for being here.
Frank H. Laukien
Bruker Corporation - Chairman, CEO & President
Thank you for having us.
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
Great. So Frank, I don't know if you want to make some opening comments before we get started or I can trip right into the questions whatever you would like to do.
Frank H. Laukien
Bruker Corporation - Chairman, CEO & President
Yes. I'd love to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot